Aurobindo Pharma Limited — Updates, 12-09-2025: General Updates
12-09-2025 | 02:35 pm
12-09-2025 | 02:35 pm
Aurobindo Pharma addresses market activity, stating that Zentiva, once a rumored acquisition target, has been sold by Advent International to GTCR, a US-based PE firm. This external development likely impacted Aurobindo's share price and trading volumes.
No comments yet. Be the first to comment!
